Emphysema Studies Wellington
Wellington
Do you suffer from AATD Emphysema? Momentum Clinical Research are testing an investigational treatment that aims to reduce symptoms of Emphysema.
Description
What to expect
Ages
Open Ages
Duration
Varies
Compensation
You will be well compensated for any study related costs
Eligibility Criteria
To join this study, here’s what we’re looking for
Other inclusion criteria will apply.
Locations
AATD Emphysema can lead to early-onset lung disease.
AATD or Alpha 1 Anti-Trypsin Deficiency is an inherited condition where the body doesn't produce enough of a protein called alpha-1 antitrypsin (AAT). This protein helps protect the lungs from damage caused by enzymes released by white blood cells.
AATD can cause emphysema which damages the lungs and can results in breathing difficulties.
Momentum conducts clinical research studies that explore potential new treatments designed to ease Emphysema symptoms. Register your interest now and find out if one of our Emphysema research studies is a good fit for you.
All study treatments are free of charge and participants are paid for any study related costs.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.